Markers of Procoagulant Imbalance in Patients with Inherited Thrombophilic Syndromes

 

PDF Download Buy Article Permissions and Reprints

Summary

In 107 asymptomatic and untreated patients with inherited syndromes associated with thrombophilia (antithrombin III, protein C and protein S deficiencies), we compared in parallel two plasma peptides which reflect activation of the common coagulation pathway: the prothrombin fragment 1 + 2 (F₁₊₂) and fibrinopeptide A (FPA). Both F₁₊₂ and FPA were measured with simple, commercially available ELISA methods. High levels of F₁₊₂ or FPA were found in about one fourth of the patients as a whole. When patients were divided according to the type of inherited thrombophilie syndrome, it appeared that F₁₊₂ was more frequently elevated in protein C and protein S deficiencies than in antithrombin deficiency; and that, in general, it was no more frequently elevated than FPA. Although our data confirm the existence of a procoagulant imbalance in inherited thrombophilie syndromes due to defects of natural anticoagulant proteins, they do not confirm that such imbalance can be more frequently diagnosed by measuring F₁₊₂ levels, particularly in patients with antithrombin deficiency.

• References

• 1 Aronson DL, Stevan L, Bail AP, Franza Jr BR, Finlayson JS. Generation of the combined prothrombin activation peptide (FI.2) during the clotting of blood and plasma. J Clin Invest 1977; 60: 1410-1418
  CrossrefPubMedGoogle Scholar
• 2 Nossel HL, Yudelman I, Canfield RE. et al Measurement of fibrinopeptide A in human blood. J Clin Invest 1974; 54: 43-53
  CrossrefPubMedGoogle Scholar
• 3 Bauer KA, Rosenberg RD. The pathophysiology of the prethrombotic state in humans: insights gained from studies using marker of the hemostatic system activation. Blood 1987; 70: 343-350
  PubMedGoogle Scholar
• 4 Bauer KA, Weiss LM, Sparrow D, Vokonas PS, Rosenberg RD. Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative aging study. J Clin Invest 1987; 80: 1527-1534
  CrossrefPubMedGoogle Scholar
• 5 Bauer KA, Goodman TL, Kass BL, Rosenberg RD. Elevated factor Xa activity in the blood of asymptomatic patients with congenital antithrombin deficiency. J Clin Invest 1985; 76: 826-836
  CrossrefPubMedGoogle Scholar
• 6 Bauer KA, Broekmans AW, Bertina RM. et al Hemostatic enzyme generation in the blood of patients with hereditary protein C deficiency. Blood 1988; 71: 1418-1426
  PubMedGoogle Scholar
• 7 Mannucci PM, Bauer KA, Gringeri A. et al Thrombin generation is not increased in the blood of hemophilia B patients after the infusion of a purified factor IX concentrate. Blood 1990; 76: 2540-2545
  PubMedGoogle Scholar
• 8 Teitel JM, Bauer KA, Lau HK, Rosenberg RD. Studies of the prothrombin activation pathway utilizing radioimmunoassays for the F₂/Fi₊₂ fragment and thrombin-antithrombin complex. Blood 1982; 59: 1086-1097
  PubMedGoogle Scholar
• 9 Pelzer H, Schwarz A, Sttiber W. Determination of human prothrombin activation fragment F₁₊₂ in plasma with an antibody against a synthetic peptide. Thromb Haemostas 1991; 65: 153-159
  PubMedGoogle Scholar
• 10 Shi D, Ruiz JA, Perez LM. et al Detection of prothrombin activation with a two-site enzyme immunoassay for the fragment F₁₊₂ . Thromb Haemostas 1989; 62: 165 (Abstr)
  PubMedGoogle Scholar
• 11 Hursting M, Butman B, Steiner J. et al A quantitative ELISA for plasma prothrombin fragment 1.2 (FI.2). Blood 1989; 74 (suppl): 257a (Abstr)
  PubMedGoogle Scholar
• 12 Tripodi A, Mannucci PM. A survey of inherited thrombotic syndromes in Italy. Res Clin Lab 1989; 19: 67-74
  PubMedGoogle Scholar
• 13 Mannucci PM, Tripodi A. Laboratory screening of inherited thrombotic syndromes. Thromb Haemostas 1987; 57: 247-251
  PubMedGoogle Scholar
• 14 Bauer KA, Barzegar S, Rosenberg RD. Influence of anticoagulants used for blood collection on plasma prothrombin fragment F₁₊₂ measurements. Thromb Res 1991; 63: 617-628
  CrossrefPubMedGoogle Scholar